- Home
- Publications
- Publication Search
- Publication Details
Title
Bone markers and osteoporosis therapy
Authors
Keywords
-
Journal
Arquivos Brasileiros de Endocrinologia e Metabologia
Volume 58, Issue 5, Pages 504-513
Publisher
FapUNIFESP (SciELO)
Online
2014-08-21
DOI
10.1590/0004-2730000003384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis
- (2013) Toshitaka Nakamura et al. CALCIFIED TISSUE INTERNATIONAL
- Bone Histomorphometry of Transiliac Paired Bone Biopsies After 6 or 12 Months of Treatment With Oral Strontium Ranelate in 387 Osteoporotic Women: Randomized Comparison to Alendronate
- (2013) Pascale Chavassieux et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single- and Multiple-Dose Randomized Studies of Blosozumab, a Monoclonal Antibody Against Sclerostin, in Healthy Postmenopausal Women
- (2013) Juliet McColm et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
- (2013) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The clinical utility of bone marker measurements in osteoporosis
- (2013) Gillian Wheater et al. Journal of Translational Medicine
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
- (2013) T. Sugimoto et al. OSTEOPOROSIS INTERNATIONAL
- Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
- (2012) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment failure in osteoporosis
- (2012) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Current Recommendations for Laboratory Testing and Use of Bone Turnover Markers in Management of Osteoporosis
- (2012) Jehoon Lee et al. Annals of Laboratory Medicine
- The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years
- (2011) E. T. Middleton et al. OSTEOPOROSIS INTERNATIONAL
- Short-term bone marker responses to teriparatide and strontium ranelate in patients with osteoporosis previously treated with bisphosphonates
- (2010) Isabel Oliveira de Sousa et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
- (2010) Carola Krause et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?
- (2010) Sundeep Khosla et al. JOURNAL OF BONE AND MINERAL RESEARCH
- RANK/RANKL: Regulators of Immune Responses and Bone Physiology
- (2009) Andreas Leibbrandt et al. Annals of the New York Academy of Sciences
- Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis*
- (2009) Robert R Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years
- (2009) O. Bruyère et al. OSTEOPOROSIS INTERNATIONAL
- Randomized Trial of Once-Weekly Parathyroid Hormone (1-84) on Bone Mineral Density and Remodeling
- (2008) Dennis M. Black et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The cell biology of bone metabolism
- (2008) H K Datta et al. JOURNAL OF CLINICAL PATHOLOGY
- Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window
- (2008) John P. Bilezikian Current Osteoporosis Reports
- Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis
- (2007) Steven Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More